Neumora Therapeutics stock collapsed Thursday after its experimental depression treatment failed in the first of three ...

Key Takeaways Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.The ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

The clinical-stage biopharmaceutical company said the Phase 3 study didn't demonstrate a statistically significant improvement on the primary endpoint of change from baseline in a scale that measures ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...

CHARLOTTESVILLE, Va. (WVIR) - UVA Health is conducting a postpartum depression screening to see how it can help women who ...